insights_auto
Why is GMAB down 3,15%?
Dive Deeperchevron_right
GMAB:NASDAQ
Genmab A/S - ADR
34,55 $
arrow_downward
-3,15%(-1,12) 1D
34,39 $
arrow_downward
-0,46% (-0,16)todayPre-market
Closed: 1 հոկ, 16:00:01 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GMAB...
Open
35,25 $
High
35,80 $
Low
34,52 $
Mkt. cap
21,49 մլրդ
Avg. vol.
2,48 մլն
Volume
2,13 հզր
P/E ratio
27,22
52-wk high
35,90 $
52-wk low
23,62 $
EPS
1,27 $
Beta
0,84
Shares outstanding
624,06 մլն
No. of employees
3 հզր
Open
35,25 $
High
35,80 $
Low
34,52 $
Mkt. cap
21,49 մլրդ
Avg. vol.
2,48 մլն
Volume
2,13 հզր
P/E ratio
27,22
52-wk high
35,90 $
52-wk low
23,62 $
EPS
1,27 $
Beta
0,84
Shares outstanding
624,06 մլն
No. of employees
3 հզր
News stories
From web sources and news partners
AD HOC NEWS
·
7 ժամ առաջ
Merus leaves Nasdaq after Genmab deal: what it means for Merus stock
Stock Traders Daily
·
10 ժամ առաջ
Precision Trading with Genmab A/s (GMAB) Risk Zones
Profile
Genmab A/S is a Danish biotechnology company, founded in February 1999 by Florian Schönharting, at the time managing director of BankInvest Biomedical venture fund. The company is based in Copenhagen, Denmark – internationally, it operates through the subsidiaries Genmab B.V. in Utrecht, The Netherlands, Genmab U.S., Inc. in Princeton, New Jersey, US, Genmab K.K. in Tokyo, Japan, Genmab Germany GmbH in München, Germany and Genmab Co., Ltd. in Suzhou, China. Genmab is listed on the Copenhagen Stock Exchange in Denmark, with American depositary receipts traded on the NASDAQ in the US. Wikipedia
About Genmab A/S - ADR
CEOJan G. J. van de Winkel
Employees3,12 հզր
Founded11 հնս, 1998 թ.
Headquarters-
Sector-
Websitegenmab.com